RenovoRx Reports First Quarter 2022 Financial Results
RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today is reporting its financial results for the quarter ended March 31, 2022.
RenovoRx Reports First Quarter 2022 Financial Results
RenovoRx today is reporting its financial results for the quarter ended March 31, 2022.